A clinical study to study the effect of drug AKKINI CHOORANAM on Vali azhal keel vaayu Rheumatoid Arthritis

A prospective open labeled randomized clinical trial on Vali azhal keel vaayu rheumatoid arthritis with evaluation of trial drug Akkini chooranam

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012709

Enrollment

Registered

2018-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Vali azhal keel vaayu

Interventions

Intervention1: Akkini chooranam: 4.2g 1 varaganedai twice a day with sugar or ghee for 30 days Control Intervention1: Not applicable: Not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patient with appropriate symptoms of symmetrical joint involvement arthritis of three or more joints florid morning stiffness and swelling that lasts for few hours or days pain joint swelling especially in the inter phalangeal joint polyarthritis patient who are willing to sign consent form and undergo laboratory investigations

Exclusion criteria

Exclusion criteria: Systemic hypertension Diabetes mellitus chronic alcoholics chronic smokers Pregnancy and lactating mothers Extrapulmonary tuberculosis psoriatic arthritis Gouty arthritis chronic kidney disease

Design outcomes

Primary

Measure	Time frame
The therapeutic efficacy of trial drug Akkini chooranam on Vali azhal keel vaayuTimepoint: 30 days	—

Secondary

Measure	Time frame
The Siddha diagnostic parameters on Vazhi azhal keel vayuTimepoint: 30 days	—

Countries

India

Contacts

Public ContactA Manoharan

Government siddha medical college and

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026